Frequencies for first 10,000 rows of indi_pt variable in indi2015q4 dataset : 'Preferred Term'-level medical | terminology describing the Indication | for use | Freq. Percent Cum. ----------------------------------------+----------------------------------- Abdominal discomfort | 4 0.04 0.04 Abdominal pain | 7 0.07 0.11 Abdominal pain upper | 6 0.06 0.17 Abnormal behaviour | 1 0.01 0.18 Acarodermatitis | 1 0.01 0.19 Acne | 101 1.01 1.20 Acne cystic | 3 0.03 1.23 Acquired immunodeficiency syndrome | 7 0.07 1.30 Acral overgrowth | 1 0.01 1.31 Acromegaly | 4 0.04 1.35 Acute HIV infection | 3 0.03 1.38 Acute coronary syndrome | 10 0.10 1.48 Acute lymphocytic leukaemia | 23 0.23 1.71 Acute myeloid leukaemia | 2 0.02 1.73 Acute myocardial infarction | 1 0.01 1.74 Adenocarcinoma pancreas | 18 0.18 1.92 Adjustment disorder | 6 0.06 1.98 Adjuvant therapy | 1 0.01 1.99 Adrenal insufficiency | 3 0.03 2.02 Adverse drug reaction | 3 0.03 2.05 Adverse event | 2 0.02 2.07 Affective disorder | 15 0.15 2.22 Afterbirth pain | 5 0.05 2.27 Aggression | 2 0.02 2.29 Agitation | 3 0.03 2.32 Allergy prophylaxis | 1 0.01 2.33 Alopecia | 18 0.18 2.51 Ammonia abnormal | 1 0.01 2.52 Anaemia | 14 0.14 2.66 Anaemia prophylaxis | 1 0.01 2.67 Anaesthesia procedure | 1 0.01 2.68 Anal fistula | 1 0.01 2.69 Analgesic therapy | 5 0.05 2.74 Anaplastic astrocytoma | 9 0.09 2.83 Anaplastic oligodendroglioma | 2 0.02 2.85 Androgen deficiency | 2 0.02 2.87 Androgenetic alopecia | 13 0.13 3.00 Aneurysm ruptured | 1 0.01 3.01 Anger | 5 0.05 3.06 Angina pectoris | 10 0.10 3.16 Angiodysplasia | 2 0.02 3.18 Angiomyolipoma | 1 0.01 3.19 Angiopathy | 2 0.02 3.21 Ankylosing spondylitis | 16 0.16 3.37 Antacid therapy | 4 0.04 3.41 Antiallergic therapy | 1 0.01 3.42 Antibiotic prophylaxis | 1 0.01 3.43 Antibiotic therapy | 3 0.03 3.46 Anticoagulant therapy | 22 0.22 3.68 Antidepressant therapy | 5 0.05 3.73 Antifungal prophylaxis | 2 0.02 3.75 Antiinflammatory therapy | 1 0.01 3.76 Antioxidant therapy | 1 0.01 3.77 Antiplatelet therapy | 3 0.03 3.80 Antiretroviral therapy | 98 0.98 4.78 Antisynthetase syndrome | 1 0.01 4.79 Antitussive therapy | 1 0.01 4.80 Antiviral prophylaxis | 4 0.04 4.84 Anxiety | 92 0.92 5.76 Anxiety disorder | 7 0.07 5.83 Anxiolytic therapy | 1 0.01 5.84 Aplasia | 3 0.03 5.87 Aplasia pure red cell | 2 0.02 5.89 Arrhythmia | 10 0.10 5.99 Arterial disorder | 1 0.01 6.00 Arterial thrombosis | 1 0.01 6.01 Arteriosclerosis | 2 0.02 6.03 Arteritis | 1 0.01 6.04 Arthralgia | 11 0.11 6.15 Arthritis | 13 0.13 6.28 Arthropathy | 10 0.10 6.38 Arthropod bite | 2 0.02 6.40 Ascites | 2 0.02 6.42 Asperger's disorder | 5 0.05 6.47 Aspergillus infection | 1 0.01 6.48 Asthenia | 3 0.03 6.51 Asthma | 141 1.41 7.92 Asymptomatic HIV infection | 4 0.04 7.96 Atrial fibrillation | 27 0.27 8.23 Atrial septal defect | 1 0.01 8.24 Attention deficit/hyperactivity disor.. | 14 0.14 8.38 Autism | 2 0.02 8.40 Autoimmune thyroiditis | 2 0.02 8.42 B precursor type acute leukaemia | 6 0.06 8.48 B-cell lymphoma | 4 0.04 8.52 B-cell lymphoma recurrent | 2 0.02 8.54 Bacillus infection | 3 0.03 8.57 Back disorder | 3 0.03 8.60 Back injury | 1 0.01 8.61 Back pain | 20 0.20 8.81 Bacteraemia | 1 0.01 8.82 Bacterial infection | 2 0.02 8.84 Balance disorder | 1 0.01 8.85 Barrett's oesophagus | 11 0.11 8.96 Basal cell carcinoma | 1 0.01 8.97 Bedridden | 1 0.01 8.98 Behcet's syndrome | 3 0.03 9.01 Benign prostatic hyperplasia | 15 0.15 9.16 Biliary cirrhosis primary | 1 0.01 9.17 Bipolar I disorder | 21 0.21 9.38 Bipolar disorder | 96 0.96 10.34 Bladder cancer | 2 0.02 10.36 Bladder discomfort | 1 0.01 10.37 Bladder disorder | 8 0.08 10.45 Bladder dysfunction | 1 0.01 10.46 Bladder irrigation | 1 0.01 10.47 Blast crisis in myelogenous leukaemia | 1 0.01 10.48 Blepharitis | 1 0.01 10.49 Blood calcium decreased | 1 0.01 10.50 Blood cholesterol | 10 0.10 10.60 Blood cholesterol abnormal | 57 0.57 11.17 Blood cholesterol decreased | 1 0.01 11.18 Blood cholesterol increased | 75 0.75 11.93 Blood disorder | 2 0.02 11.95 Blood glucose abnormal | 7 0.07 12.02 Blood glucose increased | 3 0.03 12.05 Blood growth hormone | 1 0.01 12.06 Blood magnesium decreased | 3 0.03 12.09 Blood phosphorus increased | 1 0.01 12.10 Blood potassium | 1 0.01 12.11 Blood potassium abnormal | 1 0.01 12.12 Blood potassium decreased | 3 0.03 12.15 Blood pressure abnormal | 50 0.50 12.65 Blood pressure decreased | 1 0.01 12.66 Blood pressure increased | 2 0.02 12.68 Blood pressure measurement | 13 0.13 12.81 Blood testosterone decreased | 1 0.01 12.82 Blood testosterone increased | 1 0.01 12.83 Blood triglycerides increased | 4 0.04 12.87 Bone cancer | 3 0.03 12.90 Bone density abnormal | 1 0.01 12.91 Bone density decreased | 2 0.02 12.93 Bone disorder | 9 0.09 13.02 Bone loss | 1 0.01 13.03 Bone marrow conditioning regimen | 5 0.05 13.08 Bone pain | 2 0.02 13.10 Brain neoplasm | 3 0.03 13.13 Brain neoplasm benign | 1 0.01 13.14 Brain neoplasm malignant | 9 0.09 13.23 Breakthrough pain | 3 0.03 13.26 Breast cancer | 38 0.38 13.64 Breast cancer female | 5 0.05 13.69 Breast cancer metastatic | 25 0.25 13.94 Breast cancer stage II | 1 0.01 13.95 Breast cancer stage IV | 1 0.01 13.96 Bronchiectasis | 1 0.01 13.97 Bronchitis | 8 0.08 14.05 Bronchitis chronic | 3 0.03 14.08 Calculus urinary | 1 0.01 14.09 Candida test positive | 1 0.01 14.10 Carcinoid tumour | 3 0.03 14.13 Carcinoid tumour of the small bowel | 2 0.02 14.15 Cardiac arrest | 1 0.01 14.16 Cardiac disorder | 73 0.73 14.89 Cardiac failure | 63 0.63 15.52 Cardiac failure chronic | 19 0.19 15.71 Cardiac failure congestive | 4 0.04 15.75 Cardiac fibrillation | 2 0.02 15.77 Cardiac flutter | 1 0.01 15.78 Cardiac murmur | 1 0.01 15.79 Cardiac operation | 1 0.01 15.80 Cardiomyopathy | 7 0.07 15.87 Cardiovascular disorder | 4 0.04 15.91 Cardiovascular event prophylaxis | 1 0.01 15.92 Cataract | 1 0.01 15.93 Cellulitis | 5 0.05 15.98 Central nervous system lupus | 1 0.01 15.99 Cerebral infarction | 3 0.03 16.02 Cerebral thrombosis | 1 0.01 16.03 Cerebrovascular accident | 5 0.05 16.08 Cerebrovascular accident prophylaxis | 11 0.11 16.19 Chemotherapy | 10 0.10 16.29 Chest discomfort | 2 0.02 16.31 Chest pain | 9 0.09 16.40 Choking | 1 0.01 16.41 Cholangiocarcinoma | 3 0.03 16.44 Chronic gastritis | 8 0.08 16.52 Chronic hepatitis | 1 0.01 16.53 Chronic hepatitis B | 1 0.01 16.54 Chronic hepatitis C | 84 0.84 17.38 Chronic kidney disease | 4 0.04 17.42 Chronic lymphocytic leukaemia | 27 0.27 17.69 Chronic myeloid leukaemia | 28 0.28 17.97 Chronic obstructive pulmonary disease | 47 0.47 18.44 Chronic sinusitis | 2 0.02 18.46 Circadian rhythm sleep disorder | 1 0.01 18.47 Clostridium difficile infection | 1 0.01 18.48 Coagulopathy | 2 0.02 18.50 Cogan's syndrome | 2 0.02 18.52 Cognitive disorder | 2 0.02 18.54 Colitis | 1 0.01 18.55 Colitis ulcerative | 5 0.05 18.60 Colon cancer | 7 0.07 18.67 Colon cancer metastatic | 15 0.15 18.82 Colon cancer stage IV | 1 0.01 18.83 Colon injury | 1 0.01 18.84 Colorectal cancer | 21 0.21 19.05 Colorectal cancer metastatic | 38 0.38 19.43 Compression fracture | 1 0.01 19.44 Computerised tomogram abdomen | 1 0.01 19.45 Confusional state | 3 0.03 19.48 Congestive cardiomyopathy | 1 0.01 19.49 Connective tissue disorder | 1 0.01 19.50 Constipation | 37 0.37 19.87 Contraception | 182 1.82 21.69 Contusion | 5 0.05 21.74 Convulsion prophylaxis | 1 0.01 21.75 Cor pulmonale chronic | 3 0.03 21.78 Coronary arterial stent insertion | 2 0.02 21.80 Coronary artery disease | 6 0.06 21.86 Cough | 8 0.08 21.94 Crohn's disease | 70 0.70 22.64 Cryopyrin associated periodic syndrome | 1 0.01 22.65 Cutaneous lupus erythematosus | 1 0.01 22.66 Cystic fibrosis | 2 0.02 22.68 Cystinosis | 2 0.02 22.70 Cystitis | 2 0.02 22.72 Cytomegalovirus infection | 1 0.01 22.73 Cytomegalovirus test positive | 1 0.01 22.74 Decreased appetite | 3 0.03 22.77 Decubitus ulcer | 1 0.01 22.78 Deep vein thrombosis | 8 0.08 22.86 Deficiency anaemia | 1 0.01 22.87 Dehydration | 1 0.01 22.88 Delusion | 1 0.01 22.89 Dementia | 1 0.01 22.90 Dementia Alzheimer's type | 1 0.01 22.91 Dental disorder prophylaxis | 1 0.01 22.92 Dependence | 1 0.01 22.93 Depersonalisation | 1 0.01 22.94 Depressed mood | 1 0.01 22.95 Depression | 123 1.23 24.18 Dermatitis | 1 0.01 24.19 Dermatitis atopic | 1 0.01 24.20 Dermatitis contact | 1 0.01 24.21 Dermatomyositis | 2 0.02 24.23 Developmental delay | 2 0.02 24.25 Developmental glaucoma | 2 0.02 24.27 Diabetes insipidus | 1 0.01 24.28 Diabetes mellitus | 133 1.33 25.61 Diabetes mellitus management | 2 0.02 25.63 Diabetic eye disease | 3 0.03 25.66 Diabetic foot infection | 1 0.01 25.67 Diabetic neuropathy | 2 0.02 25.69 Diabetic retinal oedema | 11 0.11 25.80 Diabetic retinopathy | 4 0.04 25.84 Diarrhoea | 16 0.16 26.00 Diffuse large B-cell lymphoma | 11 0.11 26.11 Discomfort | 6 0.06 26.17 Disturbance in attention | 1 0.01 26.18 Disturbance in social behaviour | 2 0.02 26.20 Diuretic therapy | 17 0.17 26.37 Dizziness | 1 0.01 26.38 Drug dependence | 1 0.01 26.39 Drug hypersensitivity | 2 0.02 26.41 Dry eye | 4 0.04 26.45 Dry mouth | 3 0.03 26.48 Dry skin | 1 0.01 26.49 Ductal adenocarcinoma of pancreas | 1 0.01 26.50 Duodenal ulcer | 7 0.07 26.57 Dysfunctional uterine bleeding | 1 0.01 26.58 Dyslipidaemia | 13 0.13 26.71 Dysmenorrhoea | 7 0.07 26.78 Dyspepsia | 37 0.37 27.15 Dysphagia | 4 0.04 27.19 Dyspnoea | 14 0.14 27.33 Dysuria | 1 0.01 27.34 Ear discomfort | 2 0.02 27.36 Eating disorder | 1 0.01 27.37 Eczema | 4 0.04 27.41 Elderly | 1 0.01 27.42 Electrolyte substitution therapy | 2 0.02 27.44 Emphysema | 4 0.04 27.48 Encephalopathy | 5 0.05 27.53 Endocarditis | 2 0.02 27.55 Endometrial adenocarcinoma | 3 0.03 27.58 Endometrial cancer | 12 0.12 27.70 Endometrial disorder | 1 0.01 27.71 Endometriosis | 11 0.11 27.82 Enema administration | 2 0.02 27.84 Enzyme supplementation | 1 0.01 27.85 Epidural anaesthesia | 1 0.01 27.86 Epigastric discomfort | 3 0.03 27.89 Epilepsy | 11 0.11 28.00 Epistaxis | 1 0.01 28.01 Erectile dysfunction | 5 0.05 28.06 Erosive oesophagitis | 1 0.01 28.07 Escherichia infection | 2 0.02 28.09 Essential hypertension | 2 0.02 28.11 Ex-tobacco user | 2 0.02 28.13 Eye allergy | 1 0.01 28.14 Eye disorder | 2 0.02 28.16 Eye infection | 1 0.01 28.17 Eye inflammation | 1 0.01 28.18 Factor VIII deficiency | 13 0.13 28.31 Fallopian tube cancer | 42 0.42 28.73 Fatigue | 5 0.05 28.78 Feeling of relaxation | 1 0.01 28.79 Fibromyalgia | 33 0.33 29.12 Fluid overload | 1 0.01 29.13 Fluid retention | 5 0.05 29.18 Foetal exposure during pregnancy | 7 0.07 29.25 Fungal infection | 3 0.03 29.28 Fungal skin infection | 1 0.01 29.29 Gait disturbance | 5 0.05 29.34 Gallbladder cancer | 1 0.01 29.35 Gastric antral vascular ectasia | 1 0.01 29.36 Gastric cancer | 4 0.04 29.40 Gastric disorder | 19 0.19 29.59 Gastric lavage | 1 0.01 29.60 Gastric operation | 1 0.01 29.61 Gastric pH decreased | 1 0.01 29.62 Gastric ulcer | 3 0.03 29.65 Gastritis | 15 0.15 29.80 Gastritis prophylaxis | 5 0.05 29.85 Gastroenteritis | 1 0.01 29.86 Gastrointestinal disorder | 7 0.07 29.93 Gastrointestinal disorder therapy | 4 0.04 29.97 Gastrointestinal motility disorder | 4 0.04 30.01 Gastrointestinal stromal tumour | 10 0.10 30.11 Gastrooesophageal reflux disease | 296 2.96 33.07 Gastrooesophageal reflux prophylaxis | 1 0.01 33.08 Generalised anxiety disorder | 4 0.04 33.12 Generalised tonic-clonic seizure | 1 0.01 33.13 Genital neoplasm malignant female | 1 0.01 33.14 Gingivitis | 1 0.01 33.15 Glaucoma | 15 0.15 33.30 Glioblastoma | 5 0.05 33.35 Glioblastoma multiforme | 4 0.04 33.39 Gliomatosis cerebri | 2 0.02 33.41 Glomerulonephritis membranous | 1 0.01 33.42 Glucose tolerance impaired | 1 0.01 33.43 Gout | 7 0.07 33.50 Graft versus host disease | 3 0.03 33.53 Graft versus host disease in skin | 1 0.01 33.54 Granulomatosis with polyangiitis | 1 0.01 33.55 Growth hormone deficiency | 3 0.03 33.58 HER-2 positive breast cancer | 13 0.13 33.71 HIV infection | 529 5.29 39.00 HIV test | 5 0.05 39.05 HIV test positive | 10 0.10 39.15 Haemarthrosis | 9 0.09 39.24 Haematopoietic stem cell mobilisation | 2 0.02 39.26 Haemoglobin decreased | 1 0.01 39.27 Haemolytic uraemic syndrome | 3 0.03 39.30 Haemorrhage | 6 0.06 39.36 Haemorrhage intracranial | 1 0.01 39.37 Haemorrhoids | 1 0.01 39.38 Haemostasis | 1 0.01 39.39 Hair disorder | 3 0.03 39.42 Hallucination | 1 0.01 39.43 Head and neck cancer | 7 0.07 39.50 Headache | 36 0.36 39.86 Heart disease congenital | 2 0.02 39.88 Heart rate abnormal | 2 0.02 39.90 Heart rate increased | 1 0.01 39.91 Heart rate irregular | 5 0.05 39.96 Heart valve incompetence | 2 0.02 39.98 Heart valve replacement | 2 0.02 40.00 Helicobacter gastritis | 1 0.01 40.01 Helicobacter infection | 9 0.09 40.10 Hepatic cirrhosis | 1 0.01 40.11 Hepatitis B | 3 0.03 40.14 Hepatitis B virus test | 1 0.01 40.15 Hepatitis C | 21 0.21 40.36 Hepatocellular carcinoma | 7 0.07 40.43 Herpes simplex | 1 0.01 40.44 Herpes virus infection | 2 0.02 40.46 Herpes zoster | 3 0.03 40.49 Hiatus hernia | 28 0.28 40.77 Hidradenitis | 3 0.03 40.80 High risk pregnancy | 2 0.02 40.82 Hip deformity | 1 0.01 40.83 Histiocytosis haematophagic | 1 0.01 40.84 Hodgkin's disease | 1 0.01 40.85 Hormone replacement therapy | 2 0.02 40.87 Hormone suppression therapy | 1 0.01 40.88 Hormone therapy | 1 0.01 40.89 Hot flush | 1 0.01 40.90 Hypercalcaemia | 1 0.01 40.91 Hyperchlorhydria | 8 0.08 40.99 Hypercholesterolaemia | 19 0.19 41.18 Hyperkalaemia | 1 0.01 41.19 Hyperlipidaemia | 22 0.22 41.41 Hyperparathyroidism secondary | 3 0.03 41.44 Hyperphosphataemia | 6 0.06 41.50 Hypersensitivity | 21 0.21 41.71 Hypertension | 246 2.46 44.17 Hyperthyroidism | 5 0.05 44.22 Hypertonic bladder | 2 0.02 44.24 Hypertriglyceridaemia | 1 0.01 44.25 Hyperuricaemia | 6 0.06 44.31 Hypoaesthesia | 1 0.01 44.32 Hypoalbuminaemia | 1 0.01 44.33 Hypocalcaemia | 1 0.01 44.34 Hypogammaglobulinaemia | 1 0.01 44.35 Hypoglycaemia | 8 0.08 44.43 Hypogonadism male | 1 0.01 44.44 Hypokalaemia | 5 0.05 44.49 Hypometabolism | 1 0.01 44.50 Hyponatraemia | 1 0.01 44.51 Hypotension | 1 0.01 44.52 Hypothyroidism | 38 0.38 44.90 Hypovitaminosis | 2 0.02 44.92 Ichthyosis | 1 0.01 44.93 IgA nephropathy | 1 0.01 44.94 Ill-defined disorder | 9 0.09 45.03 Immune system disorder | 4 0.04 45.07 Immune thrombocytopenic purpura | 5 0.05 45.12 Immune tolerance induction | 1 0.01 45.13 Immunisation | 2 0.02 45.15 Immunosuppressant drug therapy | 12 0.12 45.27 Immunosuppression | 11 0.11 45.38 In vitro fertilisation | 2 0.02 45.40 Inappropriate affect | 4 0.04 45.44 Inappropriate antidiuretic hormone se.. | 1 0.01 45.45 Incontinence | 2 0.02 45.47 Induction of anaesthesia | 1 0.01 45.48 Infantile spasms | 1 0.01 45.49 Infection | 12 0.12 45.61 Infection prophylaxis | 6 0.06 45.67 Inflammation | 6 0.06 45.73 Inflammatory bowel disease | 47 0.47 46.20 Influenza | 5 0.05 46.25 Influenza immunisation | 2 0.02 46.27 Influenza like illness | 4 0.04 46.31 Inhalation therapy | 1 0.01 46.32 Injection site reaction | 1 0.01 46.33 Insomnia | 38 0.38 46.71 Insulin resistance | 1 0.01 46.72 Intentional self-injury | 4 0.04 46.76 Interstitial lung disease | 3 0.03 46.79 Intervertebral disc degeneration | 2 0.02 46.81 Intervertebral disc protrusion | 4 0.04 46.85 Intracardiac thrombus | 1 0.01 46.86 Intracranial venous sinus thrombosis | 2 0.02 46.88 Intraocular pressure increased | 1 0.01 46.89 Invasive breast carcinoma | 9 0.09 46.98 Iron deficiency | 1 0.01 46.99 Iron deficiency anaemia | 4 0.04 47.03 Iron overload | 2 0.02 47.05 Irritability | 1 0.01 47.06 Irritable bowel syndrome | 14 0.14 47.20 Ischaemic heart disease prophylaxis | 1 0.01 47.21 Ischaemic stroke | 5 0.05 47.26 Joint effusion | 1 0.01 47.27 Joint swelling | 2 0.02 47.29 Juvenile idiopathic arthritis | 7 0.07 47.36 Klebsiella infection | 1 0.01 47.37 Knee arthroplasty | 1 0.01 47.38 Labour induction | 1 0.01 47.39 Labyrinthitis | 1 0.01 47.40 Large cell lung cancer | 6 0.06 47.46 Laxative supportive care | 2 0.02 47.48 Lennox-Gastaut syndrome | 9 0.09 47.57 Leukaemia | 4 0.04 47.61 Leukocytosis | 2 0.02 47.63 Leukopenia | 2 0.02 47.65 Lice infestation | 1 0.01 47.66 Ligament sprain | 5 0.05 47.71 Lipids abnormal | 2 0.02 47.73 Liver disorder | 3 0.03 47.76 Liver function test abnormal | 1 0.01 47.77 Liver transplant | 4 0.04 47.81 Liver transplant rejection | 1 0.01 47.82 Lung adenocarcinoma | 3 0.03 47.85 Lung cancer metastatic | 2 0.02 47.87 Lung disorder | 4 0.04 47.91 Lung infection | 1 0.01 47.92 Lung neoplasm malignant | 8 0.08 48.00 Lupus nephritis | 3 0.03 48.03 Lupus-like syndrome | 5 0.05 48.08 Lymphadenopathy | 2 0.02 48.10 Lymphoedema | 1 0.01 48.11 Lymphoma | 4 0.04 48.15 Macular degeneration | 3 0.03 48.18 Major depression | 11 0.11 48.29 Malaise | 2 0.02 48.31 Malaria prophylaxis | 1 0.01 48.32 Malignant glioma | 1 0.01 48.33 Malignant melanoma | 9 0.09 48.42 Malignant neoplasm of renal pelvis | 5 0.05 48.47 Malignant peritoneal neoplasm | 38 0.38 48.85 Malignant respiratory tract neoplasm | 2 0.02 48.87 Malignant urinary tract neoplasm | 2 0.02 48.89 Mania | 3 0.03 48.92 Mantle cell lymphoma | 16 0.16 49.08 Mass | 1 0.01 49.09 Mastectomy | 1 0.01 49.10 Maternal exposure timing unspecified | 2 0.02 49.12 Maternal therapy to enhance foetal lu.. | 1 0.01 49.13 Medical device complication | 1 0.01 49.14 Memory impairment | 1 0.01 49.15 Menopausal symptoms | 1 0.01 49.16 Menopause | 7 0.07 49.23 Menorrhagia | 18 0.18 49.41 Menstrual cycle management | 17 0.17 49.58 Menstrual disorder | 2 0.02 49.60 Menstruation irregular | 17 0.17 49.77 Mental disorder | 8 0.08 49.85 Metastases to bone | 1 0.01 49.86 Metastases to liver | 2 0.02 49.88 Metastases to nervous system | 3 0.03 49.91 Metastasis | 1 0.01 49.92 Metastatic malignant melanoma | 6 0.06 49.98 Metastatic renal cell carcinoma | 1 0.01 49.99 Metrorrhagia | 1 0.01 50.00 Migraine | 35 0.35 50.35 Migraine prophylaxis | 1 0.01 50.36 Mineral supplementation | 8 0.08 50.44 Mitral valve disease | 1 0.01 50.45 Mitral valve prolapse | 1 0.01 50.46 Mitral valve replacement | 1 0.01 50.47 Mood altered | 4 0.04 50.51 Mood swings | 3 0.03 50.54 Morphoea | 1 0.01 50.55 Mouth ulceration | 1 0.01 50.56 Muckle-Wells syndrome | 1 0.01 50.57 Mucopolysaccharidosis II | 1 0.01 50.58 Mucosal inflammation | 2 0.02 50.60 Multifocal motor neuropathy | 1 0.01 50.61 Multiple allergies | 28 0.28 50.89 Multiple sclerosis | 340 3.40 54.29 Multiple sclerosis relapse | 2 0.02 54.31 Muscle disorder | 1 0.01 54.32 Muscle injury | 1 0.01 54.33 Muscle relaxant therapy | 7 0.07 54.40 Muscle spasms | 12 0.12 54.52 Muscle spasticity | 13 0.13 54.65 Muscle tightness | 1 0.01 54.66 Musculoskeletal pain | 1 0.01 54.67 Musculoskeletal stiffness | 1 0.01 54.68 Myalgia | 6 0.06 54.74 Myasthenia gravis | 1 0.01 54.75 Mycosis fungoides | 1 0.01 54.76 Mydriasis | 2 0.02 54.78 Myelodysplastic syndrome | 5 0.05 54.83 Myocardial infarction | 17 0.17 55.00 Myocardial ischaemia | 1 0.01 55.01 Myoclonus | 2 0.02 55.03 Myositis | 1 0.01 55.04 Nasal congestion | 2 0.02 55.06 Nasal disorder | 1 0.01 55.07 Nasal dryness | 1 0.01 55.08 Nasopharyngitis | 6 0.06 55.14 Nausea | 26 0.26 55.40 Necrosis of artery | 1 0.01 55.41 Neoplasm | 8 0.08 55.49 Neoplasm malignant | 5 0.05 55.54 Neovascular age-related macular degen.. | 24 0.24 55.78 Nephrogenic anaemia | 1 0.01 55.79 Nephrotic syndrome | 1 0.01 55.80 Nerve degeneration | 1 0.01 55.81 Nerve injury | 2 0.02 55.83 Nervous system disorder | 8 0.08 55.91 Neuralgia | 17 0.17 56.08 Neuritis | 1 0.01 56.09 Neuroblastoma | 1 0.01 56.10 Neurodermatitis | 2 0.02 56.12 Neuroendocrine carcinoma | 1 0.01 56.13 Neuroendocrine tumour | 6 0.06 56.19 Neurogenic bladder | 1 0.01 56.20 Neuropathy peripheral | 10 0.10 56.30 Neutropenia | 7 0.07 56.37 Neutrophil count decreased | 1 0.01 56.38 Nicotine dependence | 1 0.01 56.39 Niemann-Pick disease | 1 0.01 56.40 Non-Hodgkin's lymphoma | 2 0.02 56.42 Non-Hodgkin's lymphoma recurrent | 1 0.01 56.43 Non-small cell lung cancer | 24 0.24 56.67 Nutritional supplementation | 3 0.03 56.70 Obsessive thoughts | 1 0.01 56.71 Obsessive-compulsive disorder | 6 0.06 56.77 Oedema | 7 0.07 56.84 Oedema peripheral | 5 0.05 56.89 Oesophageal candidiasis | 3 0.03 56.92 Oesophageal carcinoma | 4 0.04 56.96 Oesophageal disorder | 3 0.03 56.99 Oesophageal pain | 1 0.01 57.00 Oesophageal ulcer | 3 0.03 57.03 Oesophagitis | 1 0.01 57.04 Off label use | 11 0.11 57.15 Oligodendroglioma | 2 0.02 57.17 Oligomenorrhoea | 2 0.02 57.19 Oliguria | 1 0.01 57.20 Optic neuritis | 1 0.01 57.21 Oral candidiasis | 2 0.02 57.23 Oral contraception | 15 0.15 57.38 Oral pain | 1 0.01 57.39 Oropharyngeal discomfort | 1 0.01 57.40 Oropharyngeal pain | 1 0.01 57.41 Osteitis | 1 0.01 57.42 Osteoarthritis | 11 0.11 57.53 Osteopenia | 25 0.25 57.78 Osteoporosis | 77 0.77 58.55 Osteoporosis postmenopausal | 2 0.02 58.57 Osteoporosis prophylaxis | 3 0.03 58.60 Osteosarcoma | 1 0.01 58.61 Ovarian cancer | 41 0.41 59.02 Ovarian cancer metastatic | 3 0.03 59.05 Ovarian cyst | 4 0.04 59.09 Ovarian epithelial cancer | 8 0.08 59.17 Ovarian neoplasm | 1 0.01 59.18 Ovulation induction | 1 0.01 59.19 Pain | 149 1.49 60.68 Pain in extremity | 7 0.07 60.75 Pain management | 4 0.04 60.79 Palpitations | 4 0.04 60.83 Pancreas transplant | 2 0.02 60.85 Pancreatic carcinoma | 10 0.10 60.95 Pancreatic carcinoma metastatic | 7 0.07 61.02 Pancreatic enzyme abnormality | 1 0.01 61.03 Pancreatic enzymes decreased | 1 0.01 61.04 Pancreatic insufficiency | 1 0.01 61.05 Pancreatic neuroendocrine tumour | 4 0.04 61.09 Pancreatic neuroendocrine tumour meta.. | 5 0.05 61.14 Panic attack | 9 0.09 61.23 Panic disorder | 2 0.02 61.25 Paraesthesia | 2 0.02 61.27 Paranasal cyst | 1 0.01 61.28 Parapsoriasis | 1 0.01 61.29 Parathyroid disorder | 2 0.02 61.31 Parkinson's disease | 7 0.07 61.38 Parkinsonism | 1 0.01 61.39 Paroxysmal nocturnal haemoglobinuria | 11 0.11 61.50 Partial seizures | 1 0.01 61.51 Pemphigus | 2 0.02 61.53 Peptic ulcer | 3 0.03 61.56 Peripheral arterial occlusive disease | 1 0.01 61.57 Peripheral artery thrombosis | 1 0.01 61.58 Peripheral nerve injury | 1 0.01 61.59 Peripheral swelling | 3 0.03 61.62 Peritoneal dialysis | 1 0.01 61.63 Personality disorder | 1 0.01 61.64 Pharyngeal neoplasm | 1 0.01 61.65 Pharyngeal ulceration | 3 0.03 61.68 Pharyngitis streptococcal | 1 0.01 61.69 Phenylketonuria | 2 0.02 61.71 Pituitary-dependent Cushing's syndrome | 1 0.01 61.72 Pityriasis | 1 0.01 61.73 Plasma cell myeloma | 11 0.11 61.84 Platelet aggregation | 1 0.01 61.85 Pleuritic pain | 1 0.01 61.86 Pneumocystis jirovecii pneumonia | 1 0.01 61.87 Pneumonia | 22 0.22 62.09 Pollakiuria | 8 0.08 62.17 Polycystic ovaries | 11 0.11 62.28 Polyneuropathy | 1 0.01 62.29 Polyuria | 2 0.02 62.31 Post herpetic neuralgia | 1 0.01 62.32 Post-traumatic stress disorder | 10 0.10 62.42 Postoperative analgesia | 2 0.02 62.44 Pouchitis | 1 0.01 62.45 Precocious puberty | 1 0.01 62.46 Precursor T-lymphoblastic lymphoma/le.. | 3 0.03 62.49 Pregnancy | 4 0.04 62.53 Premedication | 87 0.87 63.40 Premenstrual dysphoric disorder | 14 0.14 63.54 Premenstrual syndrome | 57 0.57 64.11 Presumed ocular histoplasmosis syndrome | 1 0.01 64.12 Primary progressive multiple sclerosis | 1 0.01 64.13 Procedural pain | 1 0.01 64.14 Product used for unknown indication | 1,984 19.84 83.98 Prophylaxis | 109 1.09 85.07 Prophylaxis against HIV infection | 1 0.01 85.08 Prophylaxis against gastrointestinal .. | 5 0.05 85.13 Prophylaxis against graft versus host.. | 7 0.07 85.20 Prophylaxis against transplant reject.. | 16 0.16 85.36 Prophylaxis of nausea and vomiting | 1 0.01 85.37 Prostate cancer | 14 0.14 85.51 Prostate cancer metastatic | 3 0.03 85.54 Prostatic disorder | 7 0.07 85.61 Prostatic operation | 1 0.01 85.62 Prostatitis | 1 0.01 85.63 Proteinuria | 4 0.04 85.67 Prurigo | 1 0.01 85.68 Pruritus | 5 0.05 85.73 Pseudomonas infection | 1 0.01 85.74 Psoriasis | 109 1.09 86.83 Psoriatic arthropathy | 34 0.34 87.17 Psychotic disorder | 11 0.11 87.28 Pulmonary arterial hypertension | 38 0.38 87.66 Pulmonary embolism | 4 0.04 87.70 Pulmonary fibrosis | 1 0.01 87.71 Pulmonary hypertension | 10 0.10 87.81 Pulmonary oedema | 2 0.02 87.83 Pulmonary thrombosis | 2 0.02 87.85 Pulmonary tuberculosis | 1 0.01 87.86 Pulse abnormal | 1 0.01 87.87 Pustular psoriasis | 2 0.02 87.89 Pyrexia | 6 0.06 87.95 Pyruvate kinase deficiency anaemia | 2 0.02 87.97 Radiculopathy | 2 0.02 87.99 Rash pruritic | 1 0.01 88.00 Raynaud's phenomenon | 1 0.01 88.01 Rectal cancer | 11 0.11 88.12 Red blood cell abnormality | 1 0.01 88.13 Relapsing-remitting multiple sclerosis | 46 0.46 88.59 Renal and pancreas transplant | 5 0.05 88.64 Renal and pancreas transplant rejection | 1 0.01 88.65 Renal cancer | 3 0.03 88.68 Renal cell carcinoma | 11 0.11 88.79 Renal disorder | 3 0.03 88.82 Renal failure | 1 0.01 88.83 Renal lithiasis prophylaxis | 1 0.01 88.84 Renal transplant | 16 0.16 89.00 Respiratory disorder | 1 0.01 89.01 Respiratory tract infection | 6 0.06 89.07 Restless legs syndrome | 9 0.09 89.16 Restlessness | 1 0.01 89.17 Retinal detachment | 1 0.01 89.18 Retinal haemorrhage | 2 0.02 89.20 Retinal neovascularisation | 1 0.01 89.21 Retinal oedema | 8 0.08 89.29 Retinal vein occlusion | 7 0.07 89.36 Retinitis histoplasma | 1 0.01 89.37 Rheumatic disorder | 3 0.03 89.40 Rheumatoid arthritis | 333 3.33 92.73 Rhinitis | 1 0.01 92.74 Rhinitis allergic | 4 0.04 92.78 Rhinorrhoea | 1 0.01 92.79 Rosacea | 1 0.01 92.80 Routine health maintenance | 3 0.03 92.83 Salivary hypersecretion | 1 0.01 92.84 Sarcoma | 2 0.02 92.86 Sarcoma uterus | 1 0.01 92.87 Scar | 1 0.01 92.88 Scedosporium infection | 1 0.01 92.89 Schizoaffective disorder | 8 0.08 92.97 Schizophrenia | 54 0.54 93.51 Schizophrenia, disorganised type | 2 0.02 93.53 Schizophrenia, paranoid type | 15 0.15 93.68 Schizophrenia, undifferentiated type | 2 0.02 93.70 Sciatic nerve injury | 1 0.01 93.71 Sciatica | 1 0.01 93.72 Scleroderma | 5 0.05 93.77 Scoliosis | 3 0.03 93.80 Seasonal allergy | 4 0.04 93.84 Sedation | 2 0.02 93.86 Seizure | 35 0.35 94.21 Sepsis | 1 0.01 94.22 Sexual dysfunction | 2 0.02 94.24 Short-bowel syndrome | 1 0.01 94.25 Sialoadenitis | 2 0.02 94.27 Sickle cell anaemia | 4 0.04 94.31 Simplex virus test positive | 1 0.01 94.32 Sinus congestion | 2 0.02 94.34 Sinus disorder | 1 0.01 94.35 Sinusitis | 20 0.20 94.55 Sjogren's syndrome | 1 0.01 94.56 Skin cancer | 1 0.01 94.57 Skin disorder | 1 0.01 94.58 Skin infection | 1 0.01 94.59 Sleep apnoea syndrome | 1 0.01 94.60 Sleep disorder | 69 0.69 95.29 Sleep disorder therapy | 8 0.08 95.37 Sleep terror | 1 0.01 95.38 Small cell lung cancer metastatic | 1 0.01 95.39 Small for dates baby | 1 0.01 95.40 Smoking cessation therapy | 18 0.18 95.58 Soft tissue infection | 1 0.01 95.59 Somnolence | 1 0.01 95.60 Spinal anaesthesia | 1 0.01 95.61 Spinal column stenosis | 1 0.01 95.62 Spinal pain | 1 0.01 95.63 Splenectomy | 1 0.01 95.64 Staphylococcal infection | 2 0.02 95.66 Staphylococcal sepsis | 1 0.01 95.67 Status epilepticus | 4 0.04 95.71 Stent placement | 3 0.03 95.74 Still's disease adult onset | 1 0.01 95.75 Stomatitis | 4 0.04 95.79 Stress | 10 0.10 95.89 Suicidal behaviour | 1 0.01 95.90 Suicidal ideation | 1 0.01 95.91 Suicide attempt | 8 0.08 95.99 Supplementation therapy | 20 0.20 96.19 Supraventricular tachycardia | 1 0.01 96.20 Surgery | 1 0.01 96.21 Swelling | 1 0.01 96.22 Syncope | 1 0.01 96.23 Systemic lupus erythematosus | 6 0.06 96.29 Tachycardia | 1 0.01 96.30 Tachyphrenia | 7 0.07 96.37 Temporomandibular joint syndrome | 1 0.01 96.38 Tension headache | 2 0.02 96.40 Thalassaemia | 1 0.01 96.41 Thalassaemia beta | 1 0.01 96.42 Therapeutic embolisation | 1 0.01 96.43 Therapeutic procedure | 4 0.04 96.47 Thinking abnormal | 1 0.01 96.48 Throat irritation | 4 0.04 96.52 Throat tightness | 2 0.02 96.54 Thrombocytopenia | 1 0.01 96.55 Thrombocytosis | 1 0.01 96.56 Thrombophlebitis | 1 0.01 96.57 Thrombophlebitis superficial | 2 0.02 96.59 Thrombosis | 10 0.10 96.69 Thrombosis prophylaxis | 20 0.20 96.89 Thrombotic microangiopathy | 1 0.01 96.90 Thrombotic stroke | 1 0.01 96.91 Thrombotic thrombocytopenic purpura | 4 0.04 96.95 Thyroid cancer | 1 0.01 96.96 Thyroid disorder | 24 0.24 97.20 Thyroidectomy | 1 0.01 97.21 Thyroxine decreased | 1 0.01 97.22 Tinea pedis | 3 0.03 97.25 Tobacco user | 1 0.01 97.26 Tooth abscess | 2 0.02 97.28 Tourette's disorder | 5 0.05 97.33 Transient ischaemic attack | 5 0.05 97.38 Transitional cell carcinoma | 2 0.02 97.40 Tremor | 9 0.09 97.49 Trigeminal neuralgia | 1 0.01 97.50 Tuberculosis | 12 0.12 97.62 Type 1 diabetes mellitus | 3 0.03 97.65 Type 2 diabetes mellitus | 136 1.36 99.01 Ulcer | 13 0.13 99.14 Ulcer haemorrhage | 3 0.03 99.17 Unevaluable event | 1 0.01 99.18 Upper respiratory tract infection | 3 0.03 99.21 Upper respiratory tract inflammation | 1 0.01 99.22 Urge incontinence | 1 0.01 99.23 Urinary incontinence | 2 0.02 99.25 Urinary retention | 3 0.03 99.28 Urinary tract infection | 7 0.07 99.35 Urinary tract inflammation | 1 0.01 99.36 Urticaria | 2 0.02 99.38 Uterine cervical exfoliation | 3 0.03 99.41 Uterine haemorrhage | 1 0.01 99.42 Uterine hypotonus | 1 0.01 99.43 Uterine leiomyoma | 1 0.01 99.44 Vaginal haemorrhage | 5 0.05 99.49 Varices oesophageal | 1 0.01 99.50 Varicose vein | 1 0.01 99.51 Vasculitis | 2 0.02 99.53 Vasculitis cerebral | 1 0.01 99.54 Venous occlusion | 4 0.04 99.58 Venous thrombosis | 1 0.01 99.59 Ventricular dysfunction | 1 0.01 99.60 Vipoma | 3 0.03 99.63 Vitamin B12 abnormal | 1 0.01 99.64 Vitamin D | 1 0.01 99.65 Vitamin D deficiency | 2 0.02 99.67 Vitamin supplementation | 10 0.10 99.77 Vomiting | 9 0.09 99.86 Weight decreased | 8 0.08 99.94 Wheezing | 3 0.03 99.97 Withdrawal syndrome | 1 0.01 99.98 Wound infection | 1 0.01 99.99 Wound treatment | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 6 Apr 2017